PKU HealthCare (SZ:000788)2022-11-19 03:22Group 1: Company Strategy and Focus - The company will focus on three main areas: anti-infection, analgesics, and mental health, aiming to accelerate product development and registration processes [2][3] - Post-restructuring, the company plans to leverage new major shareholder resources for strategic adjustments to enhance growth and protect investor interests [3] Group 2: Business Operations and International Expansion - Currently, the company is primarily engaged in the R&D, production, and sales of chemical drug formulations, with no existing international operations [3] - Future strategic adjustments may include international expansion, depending on the resources available from new major shareholders [3] Group 3: Impact of Domestic Conditions - The company is actively managing production and operations to minimize the impact of recurring domestic COVID-19 outbreaks, ensuring stable operations [3]